Rheumatology.net

Rheumatology Xagena

Search results for "Anakinra"

Researchers from the Baylor Institute for Immunology Research in Dallas report on the successful treatment of children with systemic onset juvenile idiopathic arthritis ( SoJIA ) in whom previous ther ...


FDA ( U.S. Food and Drug Administration ) approved Humira ( Adalimumab ) for reducing signs and symptoms of active arthritis in patients with psoriatic arthritis, a chronic disease that combines the ...


The FDA ( U.S. Food and Drug Administration ) approved Humira ( Adalimumab ) for first-line treatment of recent onset moderate to severe rheumatoid arthritis ( RA ). The approval offers RA patients a ...


Orencia ( Abatacept ) SC ( subcutaneous ) and IV ( intravenous ) is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and im ...